Gastroenterology

  • Home
  • Gastroenterology
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn’s Disease

Conditions:   Granulomatous Colitis;   Crohn’s Disease;   Crohn’s Enteritis;   Granulomatous Enteritis
Interventions:   Drug: BMS-986165;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

July 27, 2018 / by / in
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis

Condition:   Colitis, Ulcerative
Interventions:   Drug: Golimumab;   Drug: Infliximab
Sponsor:   Janssen Research & Development, LLC
Not yet recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

July 25, 2018 / by / in
Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in up to 42 Adult Patients With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Condition:   Acromegaly
Interventions:   Drug: IONIS-GHR-LRx;   Drug: Placebo
Sponsor:   Ionis Pharmaceuticals, Inc.
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

July 17, 2018 / by / in
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Conditions:   Liver Fibrosis;   Nonalcoholic Fatty Liver Disease (NAFLD);   Nonalcoholic Steatohepatitis
Interventions:   Drug: BMS-986036;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

July 8, 2018 / by / in
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Conditions:   Hepatic Cirrhosis;   Liver Fibrosis;   Nonalcoholic Fatty Liver Disease (NAFLD);   Nonalcoholic Steatohepatitis
Interventions:   Drug: BMS-986036;   Other: Placebo
Sponsor:   Bristol-Myers Squibb
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

July 7, 2018 / by / in
A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation

Condition:   Irritable Bowel Syndrome Characterized by Constipation
Interventions:   Drug: Linaclotide;   Drug: Placebo
Sponsors:   Ironwood Pharmaceuticals, Inc.;   Allergan Sales, LLC
Recruiting
ClinicalTrials.gov: Gastroenterology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

July 5, 2018 / by / in